Myopia Treatment Devices Market Summary<\/b><\/p>\n To read more about the latest highlights related to the myopia treatment devices market, get a snapshot of the key highlights entailed in the Global Myopia Treatment Devices Market Forecast Report<\/b><\/a><\/p>\n Key Factors Contributing to the Rise in Growth of the Myopia Treatment Devices Market<\/b><\/a><\/p>\n Rising Prevalence of Myopia<\/b><\/p>\n The global increase in myopia, particularly among children and young adults, is a major driver. Lifestyle changes, such as prolonged screen time, reduced outdoor activities, and increased near-work tasks, have contributed to higher rates of refractive errors, creating a greater demand for corrective and treatment devices.<\/p>\n Technological Advancements in Devices<\/b><\/p>\n Innovations in optical, pharmacological, and surgical devices, such as orthokeratology lenses, atropine eye drops, and advanced contact lenses, have improved the safety, efficacy, and convenience of myopia management. These technological improvements encourage adoption among both patients and eye care professionals.<\/p>\n Increasing Awareness of Eye Health<\/b><\/p>\n Public awareness campaigns and educational programs emphasizing the importance of early detection and management of myopia are boosting patient adoption of treatment devices. Parents and caregivers are increasingly seeking preventive measures to slow the progression of myopia in children.<\/p>\n Growing Healthcare Infrastructure<\/b><\/p>\n Regions with robust healthcare systems, availability of eye care specialists, and accessibility to advanced ophthalmic equipment support the expansion of the myopia treatment devices market. This infrastructure facilitates better diagnosis, prescription, and monitoring of treatment devices.<\/p>\n Favorable Reimbursement Policies<\/b><\/p>\n Insurance coverage and reimbursement schemes for eye care devices in certain countries reduce the out-of-pocket burden on patients, making myopia treatment devices more affordable and increasing market penetration.<\/p>\n Urbanization and Lifestyle Changes<\/b><\/p>\n Urban populations often experience higher levels of myopia due to increased near-vision activities and reduced outdoor exposure. The growing urban demographic, particularly in Asia and North America, directly correlates with rising demand for corrective and preventive devices.<\/p>\n Get a sneak peek at the myopia treatment devices market dynamics @ Myopia Treatment Devices Market Trends<\/b><\/a><\/p>\n Regional Myopia Treatment Devices Market Insights<\/b><\/p>\n In 2024, North America held the largest portion of the myopia treatment devices market, accounting for 34%. The high prevalence of refractive errors, robust healthcare infrastructure, and ongoing technological innovations drive this growth. Additionally, strong public awareness of eye health and favorable reimbursement policies further support the adoption of advanced treatment solutions in the region.<\/p>\n Europe also plays a significant role in the expansion of the myopia treatment devices market. The region benefits from a well-developed healthcare system, widespread awareness of eye care, and rapid adoption of cutting-edge technologies. A comprehensive network of ophthalmic clinics offers a broad spectrum of treatments, ranging from conventional eyeglasses and contact lenses to laser-based procedures and innovative myopia control products.<\/p>\n The Asia-Pacific region is rapidly emerging as a significant growth market for myopia treatment devices, driven by the increasing incidence of myopia, particularly among children and young adults in countries such as China, Japan, South Korea, and India. Contributing factors include prolonged screen exposure, intense educational pressures, and limited outdoor activities, resulting in a large population in need of both corrective and preventive interventions.<\/p>\n To know more about why North America is leading the market growth in the myopia treatment devices market, get a snapshot of the Myopia Treatment Devices Market Share<\/b><\/a><\/p>\n Recent Developmental Activities in the Myopia Treatment Devices Market<\/b><\/p>\n What are Myopia Treatment Devices?<\/b><\/p>\n Myopia treatment devices have emerged as practical solutions to slow the progression of nearsightedness and reduce dependence on corrective eyewear. One of the most widely adopted options is orthokeratology (Ortho-K) lenses, which are specially designed rigid contact lenses worn overnight to temporarily reshape the cornea, allowing for clear vision during the day without the need for glasses or lenses. Additionally, specialized soft contact lenses, such as dual-focus or multifocal designs, have been developed to control myopia progression in children by reducing peripheral hyperopic defocus. These devices not only improve visual clarity but also target the underlying mechanisms that drive the elongation of the eyeball, which is a key factor in the progression of myopia.<\/p>\n Myopia Treatment Devices Market Assessment<\/b><\/p>\n Which MedTech key players in the myopia treatment devices market are set to emerge as the trendsetter explore @ Myopia Treatment Devices Market Analysis<\/b><\/a><\/p>\n Table of Contents\u00a0<\/b><\/p>\n Interested in knowing the myopia treatment devices market by 2032? Click to get a snapshot of the Myopia Treatment Devices Market Assessment\u00a0<\/b><\/a><\/p>\n Related Reports<\/b><\/p>\n Myopia Market<\/b><\/a><\/p>\n Myopia Market Insights, Epidemiology, and Market Forecast \u2013 2034 <\/b>report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key myopia companies, including Cloudbreak Pharma, Sunhawk Vision Biotech, Inc., iVeena Delivery Systems, Inc., Stuart Therapeutics, <\/b>among others.<\/p>\n Myopia Clinical Trial Analysis<\/b><\/a><\/p>\n Myopia Pipeline Insight <\/b>\u2013 2025<\/b> report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key myopia companies, including Cloudbreak Pharma, Sunhawk Vision Biotech, Inc., iVeena Delivery Systems, Inc., Stuart Therapeutics,\u00a0 <\/b>among others.<\/p>\n Adult Myopia Market<\/b><\/a><\/p>\n Adult Myopia Market Insights, Epidemiology, and Market Forecast \u2013 2034 <\/b>report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key adult myopia companies, including Genentech, Bayer AG, <\/b>among others.<\/p>\n Contact Lenses Market<\/b><\/a><\/p>\n Contact Lenses Market Insights, Competitive Landscape, and Market Forecast \u2013 2032 <\/b>report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key contact lenses companies, including Alcon Inc., Cooper Vision Inc., Johnson & Johnson Vision, Bausch Health Companies Inc., HOYA Vision Care Company, Contamac, ZEISS Group, SynergEyes, Menicon Co., Ltd., Gelflex, Orion Vision Group, Solotica, medios, SEED CO. LTD, <\/b>among others.<\/p>\n DelveInsight\u2019s<\/b> Pharma Competitive Intelligence Service<\/b><\/a>: <\/b>Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific\/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.<\/p>\n Other Business Pharmaceutical Consulting Services<\/b><\/p>\n Healthcare Conference Coverage<\/b><\/a><\/p>\n Pipeline Assessment<\/b><\/a><\/p>\n\n
\n
\n Myopia Treatment Devices Market Report Metrics<\/b><\/td>\n Details<\/b><\/td>\n<\/tr>\n \n Coverage<\/td>\n Global<\/td>\n<\/tr>\n \n Study Period<\/td>\n 2022\u20132032<\/td>\n<\/tr>\n \n Myopia Treatment Devices Market CAGR<\/td>\n ~8%<\/td>\n<\/tr>\n \n Myopia Treatment Devices Market Size by 2032<\/td>\n ~USD 18 Billion<\/td>\n<\/tr>\n \n Key Myopia Treatment Devices Companies<\/td>\n CooperVision (CooperCompanies), Johnson & Johnson Services Inc., Essilor, Bausch & Lomb Incorporated, Menicon Co., Ltd., LUCID KOREA LTD., Alcon Inc., HOYA VISION CARE COMPANY, SynergEyes, SightGlass Vision, Inc., Ophtec BV, STAAR SURGICAL, Mark’ennovy, SCHWIND eye-tech-solutions, Euclid Systems Corporation, NIDEK USA, Inc., Esahorus srl, Falco lenses AG, and others<\/td>\n<\/tr>\n \n
\n
\n 1<\/td>\n Myopia Treatment Devices Market Report Introduction<\/td>\n<\/tr>\n \n 2<\/td>\n Myopia Treatment Devices Market Executive Summary<\/td>\n<\/tr>\n \n 3<\/td>\n Competitive Landscape<\/td>\n<\/tr>\n \n 4<\/td>\n Regulatory Analysis<\/td>\n<\/tr>\n \n 5<\/td>\n Myopia Treatment Devices Market Key Factors Analysis<\/td>\n<\/tr>\n \n 6<\/td>\n Myopia Treatment Devices Market Porter\u2019s Five Forces Analysis<\/td>\n<\/tr>\n \n 7<\/td>\n Myopia Treatment Devices Market Layout<\/td>\n<\/tr>\n \n 8<\/td>\n Myopia Treatment Devices Market Company and Product Profiles<\/td>\n<\/tr>\n \n 9<\/td>\n KOL Views<\/td>\n<\/tr>\n \n 10<\/td>\n Project Approach<\/td>\n<\/tr>\n \n 11<\/td>\n About DelveInsight<\/td>\n<\/tr>\n \n 12<\/td>\n Disclaimer & Contact Us<\/td>\n<\/tr>\n
![\"\"](\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/10\/DelveInsight-Business-Research.png\")
<\/p>\n","protected":false},"excerpt":{"rendered":"New York, USA, Oct. 09, 2025 (GLOBE NEWSWIRE) — Global Myopia Treatment Devices Market Poised for Strong Growth…\n","protected":false},"author":3,"featured_media":99951,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[64,65266,135,148758,148756,148757,67,132,68],"class_list":{"0":"post-289789","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-markets","8":"tag-business","9":"tag-delveinsight-business-research-llp","10":"tag-markets","11":"tag-myopia-treatment-device-market","12":"tag-myopia-treatment-devices","13":"tag-myopia-treatment-devices-firms","14":"tag-united-states","15":"tag-unitedstates","16":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115345415424357765","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/289789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=289789"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/289789\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/99951"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=289789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=289789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=289789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}